Isolation and characterization of metabolites derived from 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000652:urine*; D000818:Animals; D000882:Haplorhini; D008297:Male; D011412:Propanolamines / Q000652:urine*; D011817:Rabbits; D051381:Rats
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines